Characterization of the human antiporcine immune response: A prerequisite to xenotransplantation

Immunologic Research

Volumn 19, Issue 2-3, 1999, Pages 233-243

  Bothwell, Alfred L M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Costimulation; Endothelial cell; Retroviral transduction; T cell activation; T cell recognition; Tolerance suppression; Xenotransplantation

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; T LYMPHOCYTE RECEPTOR;

ANTIBODY RESPONSE; CELLULAR IMMUNITY; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HUMAN; IMMUNOGENETICS; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; REVIEW; SWINE; XENOTRANSPLANTATION;

EID: 0032814006     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02786491     Document Type: Review

References (43)

1. Fabre JW: Nudging xenotransplantation towards humans. Nature Med 1995;1:403-404.
2. Zhao J, Rollins S, Maher SE, Bothwell ALM, Sims PJ: Amplified gene expression in CD59- transfected CHO cells confers protection against the membrane attack complex of human complement. J Biol Chem 1991;266: 13418-13422.
3. Dvorak HF, Mihm MC, Dvorak AM, Johnson RA, Manseau EJ, Morgan E, et al.: Morphology of delayed type hypersensitivity reactions in man. I Quantitative description of the inflammatory response. Lab Invest 1974;31: 111-130.
4. Mason DW, Morris PJ: Effector mechanisms in allograft rejection. Annu Rev Immunol 1986;4:119-145.
5. Pardi R, Bender JR: Signal requirements for the generation of CD4+ and CD8+ T cell responses to human allogeneic microvascular endothelium. Circ Res 1991;69:1269-1279.
6. Rosenberg AS, Singer A: Cellular basis of skin allograft rejection: an in vivo model of immune-mediated tissue destruction. Annu Rev Immunol 1992;10:333-358.
7. Lafferty KJ, Prowse SJ, Simeonovic CJ, Warren HS: Immunobiology of tissue transplantation: a return to the passenger leukocyte concept. Annu Rev Immunol 1983; 1:143-173.
8. Salomon RN, Hughes CCW, Schoen FJ, Payne DD, Pober JS, Libby P: Human coronary transplantation-associated arteriosclerosis: Evidence for a chronic immune reaction to activated graft endothelial cells. Am J Pathol 1991;138:791-798.
9. LeClair KP, Palfree RGE, Flood PM, Hammerling U, Bothwell ALM: Isolation of a murine Ly-6 cDNA reveals a new multigene family. EMBO J 1986;5:3227-3234.
10. Davies A, Simmons DL, Hale G, Harrison RA, Tighe H, Lachmann PJ, et al.: CD59, an Ly-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells. J Exp Med 1989;170:637-654.
11. Okada H, Nagami Y, Takahashi K, Okada N, Hideshima T, Takizawa H, et al.: 20 KDa homologous restriction factor of complement resembles T cell activating protein. Biochem Biophys Res Commun 1989;162:1553-1559.
12. Sawada R, Ohashi K, Okano K, Hattori M, Minato N, Naruto M: Complementary DNA sequence and deduced peptide sequence for CD59/MEM-43 antigen, the human homologue of murine lymphocyte antigen Ly-6C Nucleic Acids Res 1989;17:6728.
13. Philbrick WM,Palfree RGE, Maher S, Bridgett MM, Sirlin S, Bothwell ALM: The CD59 antigen is a structural homologue of murine Ly-6 antigens but lacks interferon inducibility. Eur J Immunol 1990;20: 87-92.
14. Kieffer B, Driscoll PC, Campbell ID, Willis AC, van der Merwe PA, Davis SJ: Three-dimensional solution structure of the extracellular region of the complement regulatory protein CD59, a new cell-surface protein domain related to snake venom neurotoxins. Biochemistry 1994;33:4471-4482.
15. Ninomiya H, Stewart BH, Rollins SA, Zhao J, Bothwell ALM, Sims PJ: Contribution of the N-linked carbohydrate of erythrocyte antigen CD59 to its complement-inhibitory activity. J Biol Chem 1992;267:8404-8410.
16. Kennedy SP, Rollins SA, Burton WV, Sims PJ, Bothwell ALM, Squinto SP, et al.: Recombinant human CD59 protects porcine aortic endothelial cells from complement-mediated cell lysis and activation: strategy for prevention of hyperacute rejection in xenogeneic transplantation. Transplantation 1994;57:1494-1501.
17. Korty PE, Brando C, Shevach EM: CD59 functions as a signal-transducing molecule for human T cell activation. J Immunol 1991;146: 4092-4098.
18. Groux H, Huet S, Aubrit F, Tran HC, Boumsell L, Bernard A: A 19-kDa human erythrocyte molecule H19 is involved in rosettes, present on nucleated cells, and required for T cell activation. J Immunol 1989;142:3013-3020.
19. Hahn WC, Menu E, Bothwell ALM, Sims PJ, Bierer BE: Overlapping but nonidentical binding sites on CD2 for CD58 and a second ligand CD59. Science 1992; 256:1805-1807.
20. Menu E, Tsai BC, Bothwell ALM, Sims PJ, Bierer BE: CD59 costimulation of T cell activation: CD58- dependence and requirement for glycosylation. J Immunol 1994; 153:2444-2456.
21. Deckert M, Kubar J, Bernard A: CD58 and CD59 molecules exhibit potentializing effects in T cell adhesion and activation. J Immunol 1992;148:672-677.
22. Deckert M, Kubar J, Zoccola D, Bernard-Pomier G, Angelisova P, Horejsi V, et al: CD59 molecule: A second ligand for CD2 in T cell adhesion. Eur J Immunol 1992; 22:2943-2947.
23. Arulanandam ARN, Moingcon P, Concino MF, Recny MA, Kalo K, Yagita H, et al.: A soluble multimeric recombinant CD2 protein identifies CD48 as a low affinity ligand for human CD2: Divergence of CD2 ligands during the evolution of humans and mice. J Exp Med 1993;177:1439-1450.
24. van der Merwe PA, Barclay AN, Mason DW, Davies EA, Morgan BP, Tone M, et al.: Human cell-adhesion molecule CD2 binds CD58 (LFA-3) with a very low affinity and an extremely fast dissociation rate but does not bind CD48 or CD59. Biochemistry 1994;33;10,149-10,160.
25. Maher SL, Pflugh DL, Larsen NJ, Rothschild MF, Bothwell ALM: Structure/function characterization of porcine CD59: Expression, chromosomal mapping, complement-inhibition, and costimulatory activity. Transplantation 1998;66: 1094-1100.
26. Murray AG, Khodadoust MM, Pober JP, Bothwell ALM: Porcine aortic endothelial cells activate human T cells: Direct presentation of MHC antigens and costimulation by ligands for human CD2 and CD2K. Immunity 1994;1:11-17.
27. Khodadoust MK, Candal FJ, Maher SE, Murray AG, Pober JS, Davis WC, et al.: PEC-A: An immortalized porcine aortic endothelial cell. Xenotransplant 1995;2:79-87.
28. Seine K, Azuma M, Bashuda H, Fukao K, Yagita H, Okumura K: CD86 (B70/B7-2) on endothelial cells co-stimulates allogeneic CD4+ T cells. Int Immunol 1995; 7:1331-1337.
29. Epperson DE, Pober JS: Antigen-presenting function of human endothelial cells, direct activation of resting CD8 T cells. J Immunol 1994;153:5402-5412.
30. Freeman GJ, Boussiotis VA, Anumanthan A, Bernstein GM, KcX-Y, Rennert PD, et al.: B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 1995;2:523-532.
31. Moses RD, Auchincloss H Jr.: Mechanisms of cellular xenograft rejection, in Cooper DKC, Kemp E, Reemtsma K, White DJG (eds.), Xenotransplantation - The Transplantation of Organs and Tissues Between Species. Springer-Verlag, New York, 1991, pp. 101-120.
32. Moses RD, Pierson RNI, Winn HJ, Auchincloss H Jr.: Xenogeneic proliferation and lymphokine production are dependent on CD4+ helper T cells and self antigen-presenting cells in the mouse. J Exp Med 1990;172: 567-575.
33. Pierson RNI, Winn HJ, Russell PS, Auchincloss H Jr.: Xenogeneic skin graft rejection is especially dependent on CD4+ T cells. J Exp Med 1989;170:991-996.
34. Fabre JW: Rat kidney allograft model: was it all too good to be true? Transplantation 1982;34: 223-225.
35. Schuler W, Weiler IJ, Schuler A, Philips RA, Rosenberg N, Mak TW, et al.: Rearrangement of antigen receptor genes is defective in mice with Severe Combined Immune Deficiency. Cell 1986; 46:963-972.
36. McCune JM, Namikawa R, Kaneshima H, Shultz LD, Lieberman M, Weissman IL: The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 1988;241: 1632-1639.
37. Mosier DE, Guliza, RJ, Torbett BE, Baird SM, Wilson DB: Break for SCIDs [Letter], Nature 1991; 353:509.
38. Mosier DE, Gulizia RJ, Baird SM, Wilson DB: Transfer of a functional immune system to mice with severe combined immunodeficiency. Nature 1988;335:256-259.
39. Murray AG, Petzelbauer P, Hughes CCW, Costa J, Askenase P, Pober JS: Human T cell-mediated destruction of allogeneic dermal microvessels in a SCTD mouse. Proc Natl Acad Sci USA 1994;91:9146-9150.
40. Murray AG, Sultan P, Madison JF, Hughes CCW, Epperson DE, Askenase P, et al.: Human anti-porcine xenogeneic reactions in the chimeric huPBL-SCID mouse: initiation of graft injury by porcine interferon-γ. The Third International Congress for Xenotransplantation 1995; Boston.
41. Montesano R, Orci L, Vassali P: In vitro rapid organisation of endothelial cells into capillary-like networks is promoted by collagen matrices. J Cell Biol 1983;97: 1648-1652.
42. Zhao X-J, Zhao J, Zhou Q, Sims PJ: Identity of the residues responsible for species restricted complement inhibitory function of human CD59. J Biol Chem 1998; 273:10665-10671.
43. Rushmere NK, Harrison RA, van den Berg CW, Morgan BP: Molecular cloning of the rat homolgue of human CD59: structural comparison with human CD59 and Identification of aputative active site. Biochem J 1994;304:595-601.